Managing GLP-1 Side Effects: Nausea, Constipation and GI Tolerability
Gastrointestinal symptoms affect 40% to 70% of patients initiating GLP-1 receptor agonists. Here is the evidence on why these adverse effects occur, practical management strategies, and how to recognise rare, serious complications.